Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04130542
Brief Title: Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (MK-3475-A31/KEYNOTE-A31) in Advanced or Metastatic Malignancy

First Submitted : October 14, 2019
First Submitted that Met QC Criteria : October 15, 2019
First Posted : October 17, 2019

Last Update Submitted that Met QC Criteria : March 17, 2021
Last Update Posted : March 19, 2021